Keywords
Cannabinoids · G-protein-coupled receptors · Cannabinoid 1 receptors ·
Cannabinoid 2 receptors · GRP55 · Palliative care · Signaling pathways ·
Apoptosis · Chemoresistance
12.1
Introduction
Cannabinoids are a group of alkaloids which are derived from the plant Cannabis
sativa. Their existence was first confirmed by China. Archaeological studies suggest
that C. sativa is cultivated for fibers since 4000 BC. The medical use of cannabis was
first mentioned in the Pen Ts’ao, a Chinese pharmacopeia (Read 1936). Later, Hua
T’o (AD 110–207), founder of Chinese surgery, used cannabis compound during
surgical procedures to anesthetize patients (Li and Lin 1974). Moreover, countries
like Nepal and India used the seeds of cannabis as spice and also for making cooking
oil (Touwn 1981). In India, cannabis seeds have been used for medicinal and
recreational purpose. Atharvaveda (Indian holy book) also mentioned cannabis use
against various diseases (Bowker 1997). In Indian traditional medicine, innumerable
functions of cannabis were identified such as analgesic, anticonvulsant, hypnotic,
tranquilizer, anesthetic, anti-inflammatory, antibiotic, antiparasitic, antispasmodic,
appetite stimulant, digestive, aphrodisiac, diuretic, and expectorant (Mikuriya 1969;
Aldrich 1997). Cannabis was considered sacred in Tibet and used to facilitate
meditation. However, over time, cannabis extracts have been explored worldwide.
In 1854, cannabis was included in the US dispensatory and was available in
pharmacies of western countries (Robson 2001). Meanwhile, at the same time,
recreational use of cannabis rapidly started spreading among the adult population
apart from its medicinal uses. Subsequently, possession or trading of cannabis
became an offense by law throughout the USA. As a result, cannabis extract and
its constituents were removed from the US pharmacopeia in 1942 and lost its
therapeutic legitimacy (Kandel 1984). In 1996, California was the first state to
pass Medical Marijuana Law (MML). As of January 2016, majority of US states
lifted the prohibition barriers and started considering outright legalization. As a
result, 25 additional states have legalized marijuana for medicinal use and 5 states
legalized for recreational use (Pacula and Smart 2017).
12.2
Discovery
A renewed interest in the studies about cannabis began in the late twentieth century.
Two researchers in 1964, Gaoni and Mechoulam, identified Δ9 THC as the major
psychoactive ingredient of C. sativa (Mechoulam and Gaoni 1965). This discovery
became the milestone toward identifying other compounds of cannabis. In 1987, two
new potent cannabinoid agonists HU-210 and desacetyl-L-nantradol were developed
(Melvin and Johnson 1987). The receptors on which they act are called the
180
S. Singh et al.